Report Detail
Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2019
- RnM3864402 |
- 10 January, 2020 |
- Global |
- 104 Pages |
- GlobalData |
- Medical Devices & Consumables
Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, “Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Peripheral Embolic Protection Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Embolic Protection Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Peripheral Embolic Protection Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
- 1.1 List of Tables 5
- 1.2 List of Figures 6
2 Introduction 7
- 2.1 Peripheral Embolic Protection Devices Overview 7
3 Products under Development 8
- 3.1 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 8
- 3.2 Peripheral Embolic Protection Devices - Pipeline Products by Segment 9
- 3.3 Peripheral Embolic Protection Devices - Pipeline Products by Territory 10
- 3.4 Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path 11
- 3.5 Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date 12
- 3.6 Peripheral Embolic Protection Devices - Ongoing Clinical Trials 13
4 Peripheral Embolic Protection Devices - Pipeline Products under Development by Companies 14
- 4.1 Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development 14
- 4.2 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 15
5 Peripheral Embolic Protection Devices Companies and Product Overview 16
- 5.1 Abbott Vascular Inc Company Overview 16
- 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 16
- 5.2 Artio Medical Company Overview 17
- 5.2.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview 17
- 5.3 Avantec Vascular Corp Company Overview 18
- 5.3.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 18
- 5.4 BTG Plc Company Overview 19
- 5.4.1 BTG Plc Pipeline Products & Ongoing Clinical Trials Overview 19
- 5.5 Capture Vascular Inc Company Overview 20
- 5.5.1 Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 20
- 5.6 Cardio-Flow Ltd. Company Overview 22
- 5.6.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
- 5.7 Cardiovascular Systems Inc Company Overview 23
- 5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 23
- 5.8 Emboline, Inc. Company Overview 25
- 5.8.1 Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
- 5.9 Filterlex Medical Ltd Company Overview 28
- 5.9.1 Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
- 5.10 Innovative Cardiovascular Solutions, LLC Company Overview 29
- 5.10.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
- 5.11 Innovia LLC Company Overview 32
- 5.11.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 32
- 5.12 Javelin Medical Ltd Company Overview 33
- 5.12.1 Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
- 5.13 Keystone Heart Ltd Company Overview 36
- 5.13.1 Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
- 5.14 Medtronic plc Company Overview 38
- 5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 38
- 5.15 MIV Therapeutics Inc Company Overview 39
- 5.15.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
- 5.16 Neurosonix Ltd. Company Overview 40
- 5.16.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
- 5.17 Protembis GmbH Company Overview 41
- 5.17.1 Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview 41
- 5.18 University of Minnesota Company Overview 42
- 5.18.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 42
- 5.19 University of Toledo Company Overview 43
- 5.19.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 43
6 Peripheral Embolic Protection Devices- Recent Developments 44
- 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 44
- 6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 46
- 6.3 Nov 07, 2019: Penumbra reports third quarter 2019 financial results 47
- 6.4 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 48
- 6.5 Oct 23, 2019: Edwards Lifesciences reports third quarter results 50
7 Appendix 101
- 7.1 Methodology 101
- 7.2 About GlobalData 104
- 7.3 Contact Us 104
Summary:
Get latest Market Research Reports on Peripheral Embolic Protection Devices. Industry analysis & Market Report on Peripheral Embolic Protection Devices is a syndicated market report, published as Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Peripheral Embolic Protection Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
